Skip to main content
FENC logo

FENC · Fennec Pharmaceuticals Inc. · Debt

Track FENC — free
$10.62 +0.47 (+4.63%) Q2 2026 earnings call transcript
Market Cap
$355.93M
Shares
35.07M
Volume · Oct 27 93.19K Avg daily vol (3M) 184.23K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Long-term debt, including current maturities 2025-09-30 USD 19,377,000 10-Q filed 2025-11-13
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1211583 CUSIP 31447P100 13F (30d) 17 filings 17 filers Visit website Investor relations